INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Regenerative medicine laws and requirements in Louisiana. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Permit Unapproved Cell Therapies | do not explicitly permit sources differ | La. R.S. 40:1300.71-1300.79 (Hope for Louisiana Patients Law)“does not include any drug, biological product, or device derived from human primary or secondary embryonic stem cells ... but does include any drug, biological product, or device derived from human perinatal tissues, cells, and secreted factors”Note: Louisiana has no stem-cell-specific authorization or notice statute in the Matthews et al. 2024 enumeration or the Oct-2026 tracker. The Hope for Louisiana Patients Law (La. R.S. 40:1300.71-.79, Acts 2024 No. 750) is a right-to-try-style law for individualized investigational treatments 'unique to and produced exclusively for use for an individual patient, based on his own genetic profile', which expressly includes perinatal-derived products; it is not a general physician authorization for unapproved cell therapy. Stored citation La. R.S. 40:1161.1 could not be located/verified. | Link | 2026-10-09 | medium |
| Require Patient Disclosure for Cell Therapies | do not require disclosure | Matthews et al., Cytotherapy 2024 (peer-reviewed enumeration of state stem-cell laws)“laws aiming to improve patient awareness (found in California, Washington, and Vermont), and 2) laws focused on increasing patient access to untested SCIs (found in Texas, North Carolina, and Mississippi).” | Link | 2026-10-09 | medium |
| Limit Practitioner Scope for Cell Therapies | No explicit state provision; federal framework applies. sources differ | La. R.S. 40:1300.71-1300.79“does not include any drug, biological product, or device derived from human primary or secondary embryonic stem cells ... but does include any drug, biological product, or device derived from human perinatal tissues, cells, and secreted factors”Note: Louisiana has no stem-cell-specific authorization or notice statute in the Matthews et al. 2024 enumeration or the Oct-2026 tracker. The Hope for Louisiana Patients Law (La. R.S. 40:1300.71-.79, Acts 2024 No. 750) is a right-to-try-style law for individualized investigational treatments 'unique to and produced exclusively for use for an individual patient, based on his own genetic profile', which expressly includes perinatal-derived products; it is not a general physician authorization for unapproved cell therapy. Stored citation La. R.S. 40:1161.1 could not be located/verified. Who may administer under the Hope law was not verified. | Link | 2026-10-09 | medium |
| Have Cell Therapy Statute References | No stem-cell-specific statute identified; La. R.S. 40:1300.71-1300.79 (Hope for Louisiana Patients Law, Acts 2024, No. 750) covers individualized investigational treatments, including perinatal-derived products. | La. R.S. 40:1300.72“does not include any drug, biological product, or device derived from human primary or secondary embryonic stem cells ... but does include any drug, biological product, or device derived from human perinatal tissues, cells, and secreted factors”Note: Louisiana has no stem-cell-specific authorization or notice statute in the Matthews et al. 2024 enumeration or the Oct-2026 tracker. The Hope for Louisiana Patients Law (La. R.S. 40:1300.71-.79, Acts 2024 No. 750) is a right-to-try-style law for individualized investigational treatments 'unique to and produced exclusively for use for an individual patient, based on his own genetic profile', which expressly includes perinatal-derived products; it is not a general physician authorization for unapproved cell therapy. Stored citation La. R.S. 40:1161.1 could not be located/verified. | Link | 2026-10-09 | high |
View full Louisiana profile (all layers) · Report an error on this page